A Win For Tempest Therapeutics Inc.
Mon, Apr 01, 2024 at 07:11 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) jumped higher at $5.44, representing a gain of 39.1%. On Mon, Apr 01, 2024, TPST:NASDAQ hit a New 2-Week High of $5.44. The stock appeared on our News Catalysts scanner on Wed, Mar 20, 2024 at 04:36 AM in the 'MISCELLANEOUS' category. From Mon, Mar 18, 2024, the stock recorded 55.56% Up Days and 70.00% Green Days
The stock spiked on Wed, Oct 11, 2023 at $9.77 with a volume of 173M+.
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Vast Renewables Limited (VSTE:NASDAQ), 157.61%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 151.02%
- Vinco Ventures Inc. (BBIG:NASDAQ), 87.5%
- two Class A (TWOA:NYSE), 71.47%
- Mediaco Holding Inc. (MDIA:NASDAQ), 55.47%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 41.67%
- IM Cannabis Corp. (IMCC:NASDAQ), 40.02%
- SPAR Group, Inc. (SGRP:NASDAQ), 39.23%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 39.13%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 36.46%